Next Article in Journal
Enhancing the Immunogenicity of Vaccinia Virus
Next Article in Special Issue
PEDV: Insights and Advances into Types, Function, Structure, and Receptor Recognition
Previous Article in Journal
Assessment of Explicit Representation of Dynamic Viral Processes in Regional Marine Ecological Models
Previous Article in Special Issue
Advances in Crosstalk between Porcine Circoviruses and Host
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Viruses
Volume 14
Issue 7
10.3390/v14071450
viruses-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Cholesterol Biosynthesis Modulates CSFV Replication

by
Xiaodong Zou
1,†,
Feng Lin
1,†,
Yang Yang
1,
Jiahuan Chen
1,
Huanyu Zhang
1,
Linquan Li
1,
Hongsheng Ouyang
1,2,
Daxin Pang
1,2 and
Xiaochun Tang
1,2,*
1
College of Animal Sciences, Jilin University, Changchun 130062, China
2
Chongqing Research Institute, Jilin University, Chongqing 401120, China
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Viruses 2022, 14(7), 1450; https://doi.org/10.3390/v14071450
Submission received: 2 June 2022 / Revised: 22 June 2022 / Accepted: 24 June 2022 / Published: 30 June 2022
(This article belongs to the Special Issue State-of-the-Art Porcine Virus Research in China)
Browse Figures
Review Reports Versions Notes

Abstract

:
Classical swine fever (CSF) caused by the classical swine fever virus (CSFV) has resulted in severe losses to the pig industry worldwide. It has been proposed that lipid synthesis is essential for viral replication, and lipids are involved in viral protein maturation and envelope production. However, the specific crosstalk between CSFV and host cell lipid metabolism is still unknown. In this study, we found that CSFV infection increased intracellular cholesterol levels in PK-15 cells. Further analysis demonstrated that CSFV infection upregulated PCSK9 expression to block the uptake of exogenous cholesterol by LDLR and enhanced the cholesterol biosynthesis pathway, which disrupted the type I IFN response in PK-15 cells. Our findings provide new insight into the mechanisms underpinning the pathogenesis of CSFV and hint at methods for controlling the disease.

1. Introduction

Classical swine fever (CSF) is a highly contagious, economically significant, multisystemic viral disease in swine that has bad adverse effects on the pig industry worldwide [1]. The incubation period of CSF varies between 3 and 10 days, which is influenced by viral virulence and the age of infected animals. CSF is characterized by several clinicopathological signs, including high fever, constipation and/or diarrhea, and skin hemorrhages of infected animals [2]. Infected pregnant sows manifest abortions, stillbirths, mummified fetuses, and malformations [3]. As a causative agent, the classical swine fever virus (CSFV) is an enveloped, positive-sense, single-stranded RNA virus belonging to the Pestivirus genus in the Flaviviridae family. The CSFV genome possesses a single open reading frame (ORF) with a flanked non-translated region at both the end of the genome (5′- and 3′-NCRs). It encodes a polypeptide precursor of 3898 amino acids (aa) that is post-translationally cleaved into four structural proteins (C, Erns, E1, and E2) and eight non-structural proteins (Npro, p7, NS2, NS3, NS4A, NS4B, NS5A, and NS5B) by viral and cellular proteases [4].
Viruses are small intracellular parasites relying on cellular factors for replication, and the fundamental aspects of CSFV–host interactions have been well described [5]. Cytoplasmic RNA helicase A (RHA) is involved in the modulation of RNA synthesis, replication, and translation of CSFV via binding 5′- and 3′-NCRs of CSFV [6]. CSFV Npro interacts with interferon regulatory factor 3 (IRF3), IRF7, and poly(C)-binding protein 1(PCBP1) to block interferons’ (IFNs) production for viral replication [7,8,9]. In addition, CSFV Npro binds to HS-1-associated protein X-1 (HAX-1) to enhance cellular resistance to apoptosis [10]. CSFV core protein interacts with SUMO-conjugating enzyme (UBC9), small ubiquitin-like modifier (SUMO-1), and IQ motif containing GTPase activating protein 1 (IQGAP1) to maintain viral virulence [11,12]. Moreover, the interaction between CSFV core protein and osteosarcoma amplified protein 9 (OS9) inhibits the virus replication in the cell culture [13]. CSFV E2 protein interacts with cellular β-actin during the early stage of the replication cycle by affecting the intracellular transport process of CSFV or E2 protein in the cell at the post-entry step [14]. In CSFV-infected PK-15 cells, annexin a2 (Anx2) is upregulated and interacts with E2 protein to promote CSFV replication [15]. Anx2 also binds to CSFV NS5A and enhances virus assembly [16]. Moreover, CSFV NS5A protein interacts with host factors such as heat shock protein 70 (HSP70) and guanylate-binding protein 1 (GBP1) to regulate viral replication [17].
Nowadays, perturbation of lipid metabolism homeostasis emerges as an important feature during viral infections, and viruses use host lipid machinery to support their replication cycle and impair the host immune response [18]. Human cytomegalovirus (HCMV) uses a host stress response to balance the elongation of saturated/monounsaturated and polyunsaturated very-long-chain fatty acids [19]. In addition, HCMV and Middle East respiratory syndrome coronavirus (MERS-CoV) increase SREBP1 translocation to the cell nucleus for enhancing fatty acid synthesis [20,21]. Some viruses, such as the Epstein–Barr virus (EBV) and respiratory syncytial virus (RSV), upregulate the expression of fatty acid synthase (FASN) and promote lipogenic gene expression [22,23,24,25]. Other viruses, such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), hepatitis c virus (HCV), and zika virus (ZIKV), affect the trafficking, formation, and recruitment processes of cellular lipid droplets (LDs) [26,27,28,29,30,31,32]. Moreover, glutathione peroxidase 4 (GPX4) inactivation increases the production of lipid peroxidation, leading to STING carbonylation at C88, suppressing its trafficking from the endoplasmic reticulum (ER) to the Golgi complex, blocking the innate antiviral immune responses, and promoting HSV-1 replication in vivo [33]. During SARS-CoV-2 biogenesis in infected cells, the spike protein is rapidly and efficiently S-acylated via the sequential action of the ZDHHC20 and ZDHHC9 enzymes to control SARS-CoV-2 membrane lipid organization and enhance infectivity [34].
Several lines of evidence suggest the crucial role of lipid metabolism in CSFV replication. Serum lipidomic analysis of piglets infected with CSFV indicated that CSFV required free fatty acids to enhance viral replication [35]. Moreover, CSFV infection upregulates the expression of FASN and fatty acid synthesis for lipid accumulation to maintain viral replication [36,37]. However, the exact function of cellular lipid metabolism in the CSFV life cycle remains unclear.
Our study explored the crosstalk between CSFV infection and cholesterol metabolism in PK-15 cells and the underlying mechanisms. Our results showed that CSFV infection increased cellular cholesterol levels and cholesterol biosynthesis modulated CSFV replication. Moreover, PCSK9 protein expression was increased to counteract exogenous cholesterol uptake during CSFV infection. Our findings provide new insights for future anti-CSFV research, and cholesterol biosynthesis can be exploited as a potential target.

2. Materials and Methods

2.1. Cells and Virus

Porcine kidney cell line (PK-15) cells (ATCC, CCL-33) were cultured in DMEM (Gibco, Waltham, MA, USA) supplemented with 5% fetal bovine serum (FBS, thermally inactivated at 56 °C for 30 min) at 37 °C and 5% CO2 in a humidified incubator. Dr. Changchun Tu kindly provided the CSFV Shimen strain (Academy of Military Medical Sciences, Changchun, China).

2.2. Quantitative Real-Time PCR (qPCR)

Total cellular RNAs were extracted using TRNzol-A+ Reagent (Tiangen, Beijing, China) and transcribed into cDNA using FastKing RT Kit (with gDNase) (Tiangen, China) according to the manufacturer’s instructions. We then used the iCycler Thermal Cycler with iQ5 Optical Module for RT-PCR to measure fluorescence intensity and amplification plots (Bio-Rad, Hercules, CA, USA, ABI 7500, iQ5). The primers used in qPCR are listed in Supplementary Table S1.

2.3. Virus One-Step Growth Curve

PK-15 cells were seeded into 6-well plates and infected with 200 TCID50 of CSFV for 1 h, washed with PBS three times, and cultured in a fresh medium. The viral genome copies were detected at 12, 24, 36, 48, 60, 72, 84, and 96 h post-infection (hpi). A total of 200 μL of viral supernatant was harvested, viral RNA extracted, and reverse transcribed into cDNA. Then, viral genome copies of CSFV were quantified by qPCR, and the one-step growth curve was plotted according to viral genome copies.

2.4. Quantification of Cholesterol Contents

Cells were lysed and incubated at 4 °C for 30 min; then, the supernatants were collected and clarified by centrifugation at 3000 rpm. The amount of cholesterol in the samples was measured using the total cholesterol assay kit (Nanjing Jiancheng Bioengineering Institute, Nanjing, China) according to the manufacturer’s instructions. The cholesterol level was measured using an infinite 2000 PRO Microplate Reader (Tecan, Männedorf, Switzerland), and three applications monitored the absorbance of the samples. The results were normalized by the total protein concentration of each sample.

2.5. Immunofluorescence Assay (IFA)

PK-15 cells were fixed in 4% paraformaldehyde for 30 min at room temperature, washed with PBS three times, permeabilized in 0.25% Triton X-100 for 15 min, and blocked with normal goat serum for 30 min at room temperature. The cells were then incubated with mouse monoclonal antibody (mAb) WH303 specific to CSFV E2 (Bioss, China) overnight at 4 °C, followed by incubation with goat anti-rabbit IgG H&L (Alexa Fluor® 488) secondary antibody (Abcam, Boston, MA, USA) for 2 h at 37 °C, and washed with PBS three times. Finally, cell nuclei were stained with Hoechst 33,342 (Dojindo, Shanghai, China) for 10 min and observed under a fluorescence microscope.

2.6. Transcriptome Analysis

Total RNA was extracted from each group, and the construction of the RNA-seq library and sequencing of the libraries was performed by a commercial service. The Bioconductor package edgeR was used to perform differential expression analysis of the different libraries. Pathway enrichment analyses were conducted for the significant expression genes identified via the Metascape platform (http://metascape.org/, accessed on 20 April 2022) [38].

2.7. Western Blotting (WB)

PK-15 cells were lysed in cell lysis buffer containing 1 mM PMSF and incubated at 4 °C for 2 h. The supernatants were collected and clarified by centrifugation at 12,000 rpm for 30 min. Then, the protein concentration was quantified via a BCA assay kit (Beyotime, China) according to the manufacturer’s instructions. Equal amounts of proteins were diluted with 5× loading buffer, boiled for 10 min, separated on the SDS-PAGE, and electrophoretically transferred to PVDF membranes. The membranes were blocked with 5% skimmed milk in PBST, incubated with antibodies in PBST, and scanned by a Tanon-5200 Chemiluminescent Imaging System (Tanon Science and Technology, Shanghai, China). The data were analyzed by Image J software, and the primary and secondary antibodies involved in the process are shown in Supplementary Table S2.

2.8. LDL Uptake Assay

PK-15 cells were seeded into 24-well plates with 30~40% confluence and treated with a serum starvation medium for 12 h. The cells were washed with DPBS containing BSA and treated with 500 μg/mL of heparin for 1 h. Then, the cells were washed and incubated with 10 μg/mL of dil-LDL solution for 4 h at 37 °C. The cells were removed from the 37 °C incubation and rinsed with wash buffer at room temperature. Subsequently, the cell nuclei were stained with Hoechst 33,342 (Dojindo, China) for 10 min at 37 °C. Finally, the cells were fixed in 4% paraformaldehyde for 30 min at room temperature and analyzed with a fluorescent microscope.

2.9. Nile Red Staining

PK-15 cells were seeded into 12-well plates with 80~90% confluence and fixed in 4% paraformaldehyde for 30 min. Next, the cells were incubated with Nile red solution for 10 min at 37 °C and washed with PBS three times. Then, cell nuclei were stained with Hoechst 33,342 (Dojindo, China) for 10 min at 37 °C and observed under a fluorescent microscope.

2.10. Construction of Plasmid

CRISPR/Cas9-single-guide RNAs targeting LDLR, SQLE, and HSD17B7 were designed by the online software (http://crispr.mit.edu/, accessed on 20 April 2022), synthesized (Comate Bioscience, Changchun, China), annealed, and cloned into the pX330-U6-Chimeric BB-CBh-hSpCas9 empty expression vector (Addgene, 42230) or the pBluescriptSKII+U6-sgRNA(F+E) empty expression vector (Addgene, 74707).

2.11. Transfection and Genotyping of Cell Clones

PK-15 cells were electrotransfected with 30 μg plasmids in 200 μL of Opti-MEM (GIBCO, Grand Island, NY, USA) using 2 mm gap cuvettes and a BTX ECM 2001 electroporator according to the manufacturer’s instructions. After electrotransfection, the cells were cultured at 37 °C for 36 h and plated into 10-cm dishes for 7–8 days. Then, the single-cell colonies were picked and placed with amplification culture in 48-well plates. After growing to 70–80% confluence, the cell clones were digested by trypsin, and 50% of each clone was lysed by NP40 lysis buffer containing 0.45% NP-40 plus 0.6% Proteinase K. The lysate was used as the temple for genotyping-PCR amplification, and the primers are shown in the following Table 1.

2.12. Statistical Analysis

All data are expressed as the means ± standard error of the mean (SEM). The unpaired Student’s t-test determined statistical differences for two-group comparisons and one-way ANOVA with Bonferroni’s post-test for multiple group comparisons with a p-value < 0.05. All statistical analyses were completed using GraphPad Prism 7.0 software.

3. Results

3.1. CSFV Upregulates Intracellular Cholesterol Levels in PK-15 Cells

A one-step growth curve of CSFV was detected, and the results showed that the copy numbers of viral genomic RNAs peaked 48 h post-infection (hpi) (Figure 1a). Then, the intracellular cholesterol levels were examined during CSFV infection, and the results showed that intracellular cholesterol levels significantly increased in CSFV-infected PK-15 cells (Figure 1b). Further analysis showed that the correlation coefficient between CSFV replication and intracellular cholesterol contents was 0.9142, and the p-value was 0.0015, indicating that viral replication was significantly positively correlated with intracellular cholesterol contents (Figure 1c). Furthermore, Nile red staining of cholesterol in CSFV-infected PK-15 cells at 48 hpi showed that the intracellular cholesterol levels increased in CSFV-infected PK-15 cells. CSFV infection significantly increased intracellular cholesterol levels in PK-15 cells, and the two positively correlated.

3.2. CSFV Enhances Cholesterol Biosynthesis in PK-15 Cells

To further explore the effects of CSFV on intracellular cholesterol levels, CSFV-infected PK-15 cells were prepared at 48 hpi for transcriptome analysis. The analysis results of gene ontology (GO) and the Kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment showed that the “cholesterol biosynthesis pathway” was a highly enriched biological pathway in CSFV-infected PK-15 cells (Figure 2a). Moreover, the transcriptional expression analysis confirmed significant changes in genes involved in cholesterol biosynthesis in RNA-seq (Figure 2b,c). Collectively, CSFV infection altered host transcriptome levels and enhanced cholesterol biosynthesis in PK-15 cells.

3.3. The Uptake of Exogenous Cholesterol Was Blocked by PCSK9 in CSFV Infected PK15 Cells

Intracellular cholesterol levels comprise de novo synthesis and extracellular uptake. The PK-15 cells’ ability to uptake exogenous cholesterol was detected. PK-15 cells normally uptake exogenous dil-LDL, and starvation increases the uptake of dil-LDL as shown in Supplementary Figure S1a,b. Therefore, the source of increased intracellular cholesterol in CSFV-infected PK-15 cells was further investigated. PK-15 cells were treated with different cholesterol types and simultaneously infected with CSFV for 48 h. The results showed that small-molecule cholesterol (CH) rather than LDL-C could increase CSFV replication and intracellular cholesterol levels (Figure 3a,b). The Western blotting results showed that CSFV infection did not affect the LDLR level but significantly increased PCSK9 expression (Figure 3c,d). Moreover, SBC-115076, a potent PCSK9 antagonist, increased the uptake of exogenous dil-LDL during CSFV infection (Figure 3e,f) but could not enhance viral replication in PK-15 cells (Figure 3g). Further research found that LDLR knockout (LO) did not affect CSFV replication and intracellular cholesterol contents in PK-15 cells during CSFV infection (Figure 3h–j and Supplementary Figure S1c–f). Altogether, these data suggested that CSFV inhibited exogenous cholesterol uptake by upregulating PCSK9 expression.

3.4. Inhibitions of Cholesterol Biosynthesis Impaired CSFV Replication

The aforementioned results showed that increased intracellular cholesterol was not derived from LDLR uptake; therefore, we further explored the role of enhanced cholesterol biosynthesis in CSFV replication. The CRISPR/Cas9 system destroyed the cholesterol biosynthesis pathway to elucidate its effect on viral replication (Supplementary Figure S2a–c). The results showed that CSFV replication was effectively reduced in SOLE knockout (SO) and HSD17B7 knockout (HO) cells, and the effect of SQLE gene deficiency on CSFV replication was more significant than HSD17B7 gene deficiency (Figure 4a). Moreover, as shown in the results of the cholesterol assay, dil-LDL uptake, and Nile red staining, SO and HO cells maintained intracellular cholesterol homeostasis by enhancing exogenous uptake capacity when not infected with CSFV. However, in the case of CSFV infection, the intracellular cholesterol levels in SO and HO cells were significantly lower than in the control group (Figure 4b–f). Collectively, the disruption of cholesterol biosynthesis significantly decreased CSFV replication.

4. Discussion

In this study, we showed that CSFV infection increased intracellular cholesterol levels, and cholesterol biosynthesis played an important role in CSFV replication. Meanwhile, we demonstrated that increased intracellular cholesterol is derived from intracellular biosynthesis rather than exogenous uptake by LDLR.
Growing evidence indicates an intimate relationship between CSFV and the host cellular cholesterol metabolism. Studies have shown that cellular cholesterol is essential for CSFV infection, and cholesterol depletion significantly blocks virus internalization and thus inhibits CSFV infection at the initial stage [39]. Moreover, inhibiting coatomer protein I (COP I) function and Niemann-pick C1 (NPC1) expression, which impairs cholesterol transport and leads to cholesterol and virion accumulation in early endosomes, thus suppresses CSFV invasion and replication [40,41]. To our knowledge, our study is the first detailed report on alterations to intracellular cholesterol in PK-15 cells during CSFV infection. We found that intracellular cholesterol levels increased significantly and reached their highest level at 48 hpi in CSFV-infected PK-15 cells. We further analyzed the correlation between CSFV replication and intracellular cholesterol and found that viral replication was significantly positively correlated with intracellular cholesterol levels. Altogether, our findings confirmed the relationship between intracellular cholesterol and CSFV replication.
Intracellular cholesterol homeostasis is regulated dynamically by exogenous uptake and de novo biosynthesis. Acquisition of exogenous cholesterol relies on the interaction of cells with low-density lipoproteins (LDL); plasma LDL-C engages the ubiquitously expressed LDL receptor (LDLR), and the complex is internalized to allow cholesterol uptake [42]. Studies have demonstrated how HCV and vesicular stomatitis virus (VSV) utilize LDLR to enter the host cell and that LDLR-mediated internalization of LDL is vital for HCV replication [43,44,45]. Other studies have shown that enhanced cholesterol biosynthesis is involved in viral life cycles. Gamma-herpes virus and HCMV reprogram cholesterol biosynthesis and enhance cholesterol flux for optimal viral production [46,47]. The inhibition of cholesterol biosynthesis by statins significantly impairs the replication of HIV, HCV, dengue virus (DENV), influenza A virus (IAV), and coxsackievirus B3 (CVB3) [48,49,50,51,52]. In the present study, we investigated the source of elevated cholesterol and the involvement of LDLR in CSFV-infected PK-15 cells. We found that small molecule cholesterol promotes CSFV replication rather than macromolecule LDL-C. Small molecule cholesterol enters the host cell by free diffusion, whereas macromolecules (LDL-C) require the assistance of LDLR. Our findings showed that CSFV upregulated PCSK9 expression to block exogenous cholesterol uptake by LDLR, and the disrupted LDLR did not affect CSFV replication in PK-15 cells. Moreover, the inhibition of PCSK9 expression enhanced exogenous cholesterol uptake but did not increase CSFV replication. Macromolecules enter cells via active transport, which requires host cell mitochondria to provide energy. However, studies have shown that CSFV hijacks host energy metabolism by triggering mitophagy and reducing mitochondrial mass for replication [53]. Furthermore, the transcriptome results further confirmed that cholesterol biosynthesis was significantly enhanced in CSFV-infected cells, and the deletion of SQLE and HSD17B7, the key enzymes involved in cholesterol biosynthesis, significantly impaired CSFV replication. Cholesterol biosynthesis is the key source of elevated intracellular cholesterol and plays an important role in CSFV replication.
Cholesterol biosynthesis uses Acetyl-CoA as the primary building block, producing a series of intermediates such as isoprenoids and sterols from the mevalonate and lanosterol pathways, respectively [54]. Previous research reports showed that the availability of cholesterol intermediates, which serve as substrates for protein prenylation, was important for murine-gammaherpesvirus-68 (MHV68) replication [46]. The presence of the cholesterol precursor, desmosterol, appears to partially rescue HSV-1 entry in the absence of cellular cholesterol [55]. Moreover, the inhibition of lanosterol significantly decreases human rhinovirus [56]. In this study, we found that lower viral copies in SQLE knockout cells are comparable to HSD17B7 knockout cells. SQLE catalyzes the oxygenation step in cholesterol synthesis and turns isoprenoid squalene into 2,3-(S)-oxo squalene before lanosterol formation; HSD17B7 contributes to the conversion of lanosterol to zymosterol. Thus, we speculated that lanosterol might be involved in CSFV infection and play a role in viral replication.
Viruses reprogram cholesterol biosynthesis for optimal replication, and the host cells utilize type I interferon (IFN) signaling to create a positive feedback loop to maintain homeostasis [57]. Thus, we clarified the crosstalk between cholesterol and IFNs during CSFV replication. Interferon-stimulated genes (ISGs) such as ccl2, cxcl10, and mx1 and the phosphorylated TBK1 (p-TBK1) levels in CSFV-infected PK-15 cells were significantly suppressed at 48 hpi, and the disruption of the cholesterol biosynthesis pathway facilitated the expression of p-TBK1 and ISGs, as shown in Supplementary Figure S3. These data suggest that CSFV promotes cholesterol biosynthesis to attenuate type I IFN signaling for viral replication.
In conclusion, our observations highlight that CSFV infection induces the cholesterol metabolism reprogramming of host cells, which facilitates replication. Mechanistically, the upregulation of PCSK9 expression by CSFV infection blocks exogenous cholesterol uptake, thus enhancing cholesterol biosynthesis, suppressing type I IFN response, and facilitating CSFV replication. Understanding the importance of cholesterol biosynthesis in CSFV replication offers new insights for future anti-CSFV research. Further studies are warranted to elucidate the precise mechanisms between cholesterol biosynthesis and CSFV replication.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/v14071450/s1, Supplementary Figure S1: LDLR knockout had no effect on CSFV replication and intracellular cholesterol contents in PK-15 cells; Supplementary Figure S2: Cholesterol biosynthesis schematic diagram; Supplementary Figure S3: CSFV promotes cholesterol biosynthesis to attenuate type I IFN signaling for viral replication; Supplementary Table S1: The primers used in qPCR. Supplementary Table S2: The primary and secondary antibodies used in WB.

Author Contributions

Conceptualization, D.P. and X.T.; methodology, F.L. and Y.Y.; software, J.C.; validation, X.Z.; formal analysis, H.Z. and L.L.; investigation, J.C.; resources, X.T.; data curation, X.Z.; writing—original draft preparation, X.Z.; writing—review and editing, X.T.; visualization, D.P.; supervision, H.O.; project administration, H.O.; funding acquisition, X.T. All authors have read and agreed to the published version of the manuscript.

Funding

This work was financially supported by the National Natural Science Foundation of China [No. 31972710 and No. 31772747].

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Wei, Q.; Liu, Y.; Zhang, G. Research Progress and Challenges in Vaccine Development against Classical Swine Fever Virus. Viruses 2021, 13, 445. [Google Scholar] [CrossRef]
  2. Malik, Y.S.; Bhat, S.; Kumar, O.R.V.; Yadav, A.K.; Sircar, S.; Ansari, M.I.; Sarma, D.K.; Rajkhowa, T.K.; Ghosh, S.; Dhama, K. Classical Swine Fever Virus Biology, Clinicopathology, Diagnosis, Vaccines and a Meta-Analysis of Prevalence: A Review from the Indian Perspective. Pathogens 2020, 9, 500. [Google Scholar] [CrossRef]
  3. Dewulf, J.; Laevens, H.; Koenen, F.; Mintiens, K.; De Kruif, A. An experimental infection with classical swine fever virus in pregnant sows: Transmission of the virus, course of the disease, antibody response and effect on gestation. J. Vet. Med. B Infect. Dis. Vet. Public Health 2001, 48, 583–591. [Google Scholar] [CrossRef]
  4. Fan, J.; Liao, Y.; Zhang, M.; Liu, C.; Li, Z.; Li, Y.; Li, X.; Wu, K.; Yi, L.; Ding, H.; et al. Anti-Classical Swine Fever Virus Strategies. Microorganisms 2021, 9, 761. [Google Scholar] [CrossRef]
  5. Li, S.; Wang, J.; Yang, Q.; Naveed Anwar, M.; Yu, S.; Qiu, H.J. Complex Virus-Host Interactions Involved in the Regulation of Classical Swine Fever Virus Replication: A Minireview. Viruses 2017, 9, 171. [Google Scholar] [CrossRef] [Green Version]
  6. Sheng, C.; Yao, Y.; Chen, B.; Wang, Y.; Chen, J.; Xiao, M. RNA helicase is involved in the expression and replication of classical swine fever virus and interacts with untranslated region. Virus Res. 2013, 171, 257–261. [Google Scholar] [CrossRef]
  7. Bauhofer, O.; Summerfield, A.; Sakoda, Y.; Tratschin, J.D.; Hofmann, M.A.; Ruggli, N. Classical swine fever virus Npro interacts with interferon regulatory factor 3 and induces its proteasomal degradation. J. Virol. 2007, 81, 3087–3096. [Google Scholar] [CrossRef] [Green Version]
  8. Fiebach, A.R.; Guzylack-Piriou, L.; Python, S.; Summerfield, A.; Ruggli, N. Classical swine fever virus N(pro) limits type I interferon induction in plasmacytoid dendritic cells by interacting with interferon regulatory factor 7. J. Virol. 2011, 85, 8002–8011. [Google Scholar] [CrossRef] [Green Version]
  9. Li, D.; Li, S.; Sun, Y.; Dong, H.; Li, Y.; Zhao, B.; Guo, D.; Weng, C.; Qiu, H.J. Poly(C)-binding protein 1, a novel N(pro)-interacting protein involved in classical swine fever virus growth. J. Virol. 2013, 87, 2072–2080. [Google Scholar] [CrossRef] [Green Version]
  10. Johns, H.L.; Doceul, V.; Everett, H.; Crooke, H.; Charleston, B.; Seago, J. The classical swine fever virus N-terminal protease N(pro) binds to cellular HAX-1. J. Gen. Virol. 2010, 91, 2677–2686. [Google Scholar] [CrossRef]
  11. Gladue, D.P.; Holinka, L.G.; Fernandez-Sainz, I.J.; Prarat, M.V.; O’Donell, V.; Vepkhvadze, N.; Lu, Z.; Rogers, K.; Risatti, G.R.; Borca, M.V. Effects of the interactions of classical swine fever virus Core protein with proteins of the SUMOylation pathway on virulence in swine. Virology 2010, 407, 129–136. [Google Scholar] [CrossRef] [Green Version]
  12. Gladue, D.P.; Holinka, L.G.; Fernandez-Sainz, I.J.; Prarat, M.V.; O’Donnell, V.; Vepkhvadze, N.G.; Lu, Z.; Risatti, G.R.; Borca, M.V. Interaction between Core protein of classical swine fever virus with cellular IQGAP1 protein appears essential for virulence in swine. Virology 2011, 412, 68–74. [Google Scholar] [CrossRef]
  13. Gladue, D.P.; O’Donnell, V.; Fernandez-Sainz, I.J.; Fletcher, P.; Baker-Branstetter, R.; Holinka, L.G.; Sanford, B.; Carlson, J.; Lu, Z.; Borca, M.V. Interaction of structural core protein of classical swine fever virus with endoplasmic reticulum-associated degradation pathway protein OS9. Virology 2014, 460–461, 173–179. [Google Scholar] [CrossRef] [Green Version]
  14. Wright, J.F.; Kurosky, A.; Pryzdial, E.L.; Wasi, S. Host cellular annexin II is associated with cytomegalovirus particles isolated from cultured human fibroblasts. J. Virol. 1995, 69, 4784–4791. [Google Scholar] [CrossRef] [Green Version]
  15. Yang, Z.; Shi, Z.; Guo, H.; Qu, H.; Zhang, Y.; Tu, C. Annexin 2 is a host protein binding to classical swine fever virus E2 glycoprotein and promoting viral growth in PK-15 cells. Virus Res. 2015, 201, 16–23. [Google Scholar] [CrossRef]
  16. Sheng, C.; Liu, X.; Jiang, Q.; Xu, B.; Zhou, C.; Wang, Y.; Chen, J.; Xiao, M. Annexin A2 is involved in the production of classical swine fever virus infectious particles. J. Gen. Virol. 2015, 96, 1027–1032. [Google Scholar] [CrossRef]
  17. Zhang, C.; Kang, K.; Ning, P.; Peng, Y.; Lin, Z.; Cui, H.; Cao, Z.; Wang, J.; Zhang, Y. Heat shock protein 70 is associated with CSFV NS5A protein and enhances viral RNA replication. Virology 2015, 482, 9–18. [Google Scholar] [CrossRef] [Green Version]
  18. Proto, M.C.; Fiore, D.; Piscopo, C.; Pagano, C.; Galgani, M.; Bruzzaniti, S.; Laezza, C.; Gazzerro, P.; Bifulco, M. Lipid homeostasis and mevalonate pathway in COVID-19: Basic concepts and potential therapeutic targets. Prog. Lipid Res. 2021, 82, 101099. [Google Scholar] [CrossRef]
  19. Xi, Y.; Lindenmayer, L.; Kline, I.; von Einem, J.; Purdy, J.G. Human Cytomegalovirus Uses a Host Stress Response to Balance the Elongation of Saturated/Monounsaturated and Polyunsaturated Very-Long-Chain Fatty Acids. Mbio 2021, 12, e00167-21. [Google Scholar] [CrossRef]
  20. Spencer, C.M.; Schafer, X.L.; Moorman, N.J.; Munger, J. Human cytomegalovirus induces the activity and expression of acetyl-coenzyme A carboxylase, a fatty acid biosynthetic enzyme whose inhibition attenuates viral replication. J. Virol. 2011, 85, 5814–5824. [Google Scholar] [CrossRef] [Green Version]
  21. Yuan, S.; Chu, H.; Chan, J.F.; Ye, Z.W.; Wen, L.; Yan, B.; Lai, P.M.; Tee, K.M.; Huang, J.; Chen, D.; et al. SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target. Nat. Commun. 2019, 10, 120. [Google Scholar] [CrossRef]
  22. Hulse, M.; Johnson, S.M.; Boyle, S.; Caruso, L.B.; Tempera, I. Epstein-Barr Virus-Encoded Latent Membrane Protein 1 and B-Cell Growth Transformation Induce Lipogenesis through Fatty Acid Synthase. J. Virol. 2021, 95, e01857-20. [Google Scholar] [CrossRef]
  23. Wilsky, S.; Sobotta, K.; Wiesener, N.; Pilas, J.; Althof, N.; Munder, T.; Wutzler, P.; Henke, A. Inhibition of fatty acid synthase by amentoflavone reduces coxsackievirus B3 replication. Arch. Virol. 2012, 157, 259–269. [Google Scholar] [CrossRef]
  24. Ohol, Y.M.; Wang, Z.; Kemble, G.; Duke, G. Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses. PLoS ONE 2015, 10, e0144648. [Google Scholar]
  25. Kapadia, S.B.; Chisari, F.V. Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids. Proc. Natl. Acad. Sci. USA 2005, 102, 2561–2566. [Google Scholar] [CrossRef] [Green Version]
  26. Dias, S.S.G.; Soares, V.C.; Ferreira, A.C.; Sacramento, C.Q.; Fintelman-Rodrigues, N.; Temerozo, J.R.; Teixeira, L.; Nunes da Silva, M.A.; Barreto, E.; Mattos, M.; et al. Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators. PLoS Path. 2020, 16, e1009127. [Google Scholar] [CrossRef]
  27. Vogt, D.A.; Camus, G.; Herker, E.; Webster, B.R.; Tsou, C.L.; Greene, W.C.; Yen, T.S.; Ott, M. Lipid droplet-binding protein TIP47 regulates hepatitis C Virus RNA replication through interaction with the viral NS5A protein. PLoS Path. 2013, 9, e1003302. [Google Scholar] [CrossRef]
  28. Hou, W.; Cruz-Cosme, R.; Armstrong, N.; Obwolo, L.A.; Wen, F.; Hu, W.; Luo, M.H.; Tang, Q. Molecular cloning and characterization of the genes encoding the proteins of Zika virus. Gene 2017, 628, 117–128. [Google Scholar] [CrossRef] [Green Version]
  29. Samsa, M.M.; Mondotte, J.A.; Iglesias, N.G.; Assunção-Miranda, I.; Barbosa-Lima, G.; Da Poian, A.T.; Bozza, P.T.; Gamarnik, A.V. Dengue virus capsid protein usurps lipid droplets for viral particle formation. PLoS Path. 2009, 5, e1000632. [Google Scholar] [CrossRef]
  30. Martins, A.S.; Carvalho, F.A.; Faustino, A.F.; Martins, I.C.; Santos, N.C. West Nile Virus Capsid Protein Interacts with Biologically Relevant Host Lipid Systems. Front. Cell Infect. Microbiol. 2019, 9, 8. [Google Scholar] [CrossRef] [Green Version]
  31. Cheung, W.; Gill, M.; Esposito, A.; Kaminski, C.F.; Courousse, N.; Chwetzoff, S.; Trugnan, G.; Keshavan, N.; Lever, A.; Desselberger, U. Rotaviruses associate with cellular lipid droplet components to replicate in viroplasms, and compounds disrupting or blocking lipid droplets inhibit viroplasm formation and viral replication. J. Virol. 2010, 84, 6782–6798. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Episcopio, D.; Aminov, S.; Benjamin, S.; Germain, G.; Datan, E.; Landazuri, J.; Lockshin, R.A.; Zakeri, Z. Atorvastatin restricts the ability of influenza virus to generate lipid droplets and severely suppresses the replication of the virus. FASEB J. 2019, 33, 9516–9525. [Google Scholar] [CrossRef] [PubMed]
  33. Jia, M.; Qin, D.; Zhao, C.; Chai, L.; Yu, Z.; Wang, W.; Tong, L.; Lv, L.; Wang, Y.; Rehwinkel, J.; et al. Redox homeostasis maintained by GPX4 facilitates STING activation. Nat. Immunol. 2020, 21, 727–735. [Google Scholar] [CrossRef] [PubMed]
  34. Mesquita, F.S.; Abrami, L.; Sergeeva, O.; Turelli, P.; Qing, E.; Kunz, B.; Raclot, C.; Paz Montoya, J.; Abriata, L.A.; Gallagher, T.; et al. S-acylation controls SARS-CoV-2 membrane lipid organization and enhances infectivity. Dev. Cell 2021, 56, 2790–2807.e8. [Google Scholar] [CrossRef]
  35. Ma, S.; Mao, Q.; Chen, W.; Zhao, M.; Wu, K.; Song, D.; Li, X.; Zhu, E.; Fan, S.; Yi, L.; et al. Serum Lipidomics Analysis of Classical Swine Fever Virus Infection in Piglets and Emerging Role of Free Fatty Acids in Virus Replication in vitro. Front. Cell Infect. Microbiol. 2019, 9, 410. [Google Scholar] [CrossRef] [Green Version]
  36. Liu, Y.Y.; Liang, X.D.; Liu, C.C.; Cheng, Y.; Chen, H.; Baloch, A.S.; Zhang, J.; Go, Y.Y.; Zhou, B. Fatty Acid Synthase Is Involved in Classical Swine Fever Virus Replication by Interaction with NS4B. J. Virol. 2021, 95, e0078121. [Google Scholar] [CrossRef]
  37. Gao, Y.; Hu, J.H.; Liang, X.D.; Chen, J.; Liu, C.C.; Liu, Y.Y.; Cheng, Y.; Go, Y.Y.; Zhou, B. Curcumin inhibits classical swine fever virus replication by interfering with lipid metabolism. Vet. Microbiol. 2021, 259, 109152. [Google Scholar] [CrossRef]
  38. Zhou, Y.; Zhou, B.; Pache, L.; Chang, M.; Khodabakhshi, A.H.; Tanaseichuk, O.; Benner, C.; Chanda, S.K. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 2019, 10, 1523. [Google Scholar] [CrossRef]
  39. Yu, S.; Yin, C.; Song, K.; Li, S.; Zheng, G.L.; Li, L.F.; Wang, J.; Li, Y.; Luo, Y.; Sun, Y.; et al. Engagement of cellular cholesterol in the life cycle of classical swine fever virus: Its potential as an antiviral target. J. Gen. Virol. 2019, 100, 156–165. [Google Scholar] [CrossRef]
  40. Zhang, L.; Wang, T.; Yi, Y.; Song, M.; Jin, M.; Guo, K.; Zhang, Y. ARF1 with Sec7 domain-dependent GBF1 activates coatomer protein I to support classical swine fever virus entry. J. Virol. 2022, 96, e02193-21. [Google Scholar] [CrossRef]
  41. Liang, X.D.; Zhang, Y.N.; Liu, C.C.; Chen, J.; Chen, X.N.; Sattar Baloch, A.; Zhou, B. U18666A inhibits classical swine fever virus replication through interference with intracellular cholesterol trafficking. Vet. Microbiol. 2019, 238, 108436. [Google Scholar] [CrossRef] [PubMed]
  42. Aurubin, C.A.; Knaack, D.A.; Sahoo, D.; Tarakanova, V.L. Low-density lipoprotein receptor (LDL-R) suppresses endogenous cholesterol synthesis pathway to oppose gammaherpesvirus replication in primary macrophages. J. Virol. 2021, 95, e0064921. [Google Scholar] [CrossRef] [PubMed]
  43. Albecka, A.; Belouzard, S.; Op de Beeck, A.; Descamps, V.; Goueslain, L.; Bertrand-Michel, J.; Tercé, F.; Duverlie, G.; Rouillé, Y.; Dubuisson, J. Role of low-density lipoprotein receptor in the hepatitis C virus life cycle. Hepatology 2012, 55, 998–1007. [Google Scholar] [CrossRef] [PubMed]
  44. Finkelshtein, D.; Werman, A.; Novick, D.; Barak, S.; Rubinstein, M. LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus. Proc. Natl. Acad. Sci. USA 2013, 110, 7306–7311. [Google Scholar] [CrossRef] [Green Version]
  45. Syed, G.H.; Tang, H.; Khan, M.; Hassanein, T.; Liu, J.; Siddiqui, A. Hepatitis C virus stimulates low-density lipoprotein receptor expression to facilitate viral propagation. J. Virol. 2014, 88, 2519–2529. [Google Scholar] [CrossRef] [Green Version]
  46. Lange, P.T.; Darrah, E.J.; Vonderhaar, E.P.; Mboko, W.P.; Rekow, M.M.; Patel, S.B.; Sidjanin, D.J.; Tarakanova, V.L. Type I Interferon Counteracts Antiviral Effects of Statins in the Context of Gammaherpesvirus Infection. J. Virol. 2016, 90, 3342–3354. [Google Scholar] [CrossRef] [Green Version]
  47. Low, H.; Mukhamedova, N.; Cui, H.L.; McSharry, B.P.; Avdic, S.; Hoang, A.; Ditiatkovski, M.; Liu, Y.; Fu, Y.; Meikle, P.J.; et al. Cytomegalovirus Restructures Lipid Rafts via a US28/CDC42-Mediated Pathway, Enhancing Cholesterol Efflux from Host Cells. Cell Rep. 2016, 16, 186–200. [Google Scholar] [CrossRef] [Green Version]
  48. Amet, T.; Nonaka, M.; Dewan, M.Z.; Saitoh, Y.; Qi, X.; Ichinose, S.; Yamamoto, N.; Yamaoka, S. Statin-induced inhibition of HIV-1 release from latently infected U1 cells reveals a critical role for protein prenylation in HIV-1 replication. Microbes Infect. 2008, 10, 471–480. [Google Scholar] [CrossRef]
  49. Kim, S.S.; Peng, L.F.; Lin, W.; Choe, W.H.; Sakamoto, N.; Kato, N.; Ikeda, M.; Schreiber, S.L.; Chung, R.T. A cell-based, high-throughput screen for small molecule regulators of hepatitis C virus replication. Gastroenterology 2007, 132, 311–320. [Google Scholar] [CrossRef] [Green Version]
  50. Martínez-Gutierrez, M.; Castellanos, J.E.; Gallego-Gómez, J.C. Statins reduce dengue virus production via decreased virion assembly. Intervirology 2011, 54, 202–216. [Google Scholar] [CrossRef]
  51. Hui, K.P.; Kuok, D.I.; Kang, S.S.; Li, H.S.; Ng, M.M.; Bui, C.H.; Peiris, J.S.; Chan, R.W.; Chan, M.C. Modulation of sterol biosynthesis regulates viral replication and cytokine production in influenza A virus infected human alveolar epithelial cells. Antivir. Res. 2015, 119, 1–7. [Google Scholar] [CrossRef] [PubMed]
  52. Werner, B.; Dittmann, S.; Funke, C.; Überla, K.; Piper, C.; Niehaus, K.; Horstkotte, D.; Farr, M. Effect of lovastatin on coxsackievirus B3 infection in human endothelial cells. Inflamm. Res. 2014, 63, 267–276. [Google Scholar] [CrossRef] [PubMed]
  53. Zhang, L.; Qin, Y.; Chen, M. Viral strategies for triggering and manipulating mitophagy. Autophagy 2018, 14, 1665–1673. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Bah, S.Y.; Dickinson, P.; Forster, T.; Kampmann, B.; Ghazal, P. Immune oxysterols: Role in mycobacterial infection and inflammation. J. Steroid Biochem. Mol. Biol. 2017, 169, 152–163. [Google Scholar] [CrossRef] [Green Version]
  55. Wudiri, G.A.; Pritchard, S.M.; Li, H.; Liu, J.; Aguilar, H.C.; Gilk, S.D.; Nicola, A.V. Molecular requirement for sterols in herpes simplex virus entry and infectivity. J. Virol. 2014, 88, 13918–13922. [Google Scholar] [CrossRef] [Green Version]
  56. McCrae, C.; Dzgoev, A.; Ståhlman, M.; Horndahl, J.; Svärd, R.; Große, A.; Großkopf, T.; Skujat, M.A.; Williams, N.; Schubert, S.; et al. Lanosterol Synthase Regulates Human Rhinovirus Replication in Human Bronchial Epithelial Cells. Am. J. Respir. Cell Mol. Biol. 2018, 59, 713–722. [Google Scholar] [CrossRef]
  57. York, A.G.; Williams, K.J.; Argus, J.P.; Zhou, Q.D.; Brar, G.; Vergnes, L.; Gray, E.E.; Zhen, A.; Wu, N.C.; Yamada, D.H.; et al. Limiting Cholesterol Biosynthetic Flux Spontaneously Engages Type I IFN Signaling. Cell 2015, 163, 1716–1729. [Google Scholar] [CrossRef] [Green Version]
Viruses 14 01450 g001 550
Figure 1. The alterations of intracellular cholesterol in CSFV-infected PK-15 cells. (a) CSFV one-step growth curve in PK-15 cells; n = 3; **** p < 0.0001. (b) Variation curve of intracellular cholesterol contents in CSFV-infected PK-15 cells; n = 3; *** p < 0.001; **** p < 0.0001. (c) Correlation analysis of CSFV replication and intracellular cholesterol levels. (d) The CSFV E2 protein and intracellular cholesterol levels in CSFV-infected PK-15 cells were assessed by IFA and Nile red staining. (M, mock; C, CSFV).
Figure 1. The alterations of intracellular cholesterol in CSFV-infected PK-15 cells. (a) CSFV one-step growth curve in PK-15 cells; n = 3; **** p < 0.0001. (b) Variation curve of intracellular cholesterol contents in CSFV-infected PK-15 cells; n = 3; *** p < 0.001; **** p < 0.0001. (c) Correlation analysis of CSFV replication and intracellular cholesterol levels. (d) The CSFV E2 protein and intracellular cholesterol levels in CSFV-infected PK-15 cells were assessed by IFA and Nile red staining. (M, mock; C, CSFV).
Viruses 14 01450 g001
Viruses 14 01450 g002 550
Figure 2. Cholesterol biosynthesis in CSFV-infected PK-15 cells. (a) GO and KEGG enrichment for differentially expressed genes in CSFV-infected PK-15 cells. (b,c) The expression of gene involved in cholesterol biosynthesis was detected in CSFV-infected PK-15 cells; ** p < 0.01; *** p < 0.001; **** p < 0.0001. (M, mock; C, CSFV; Rel. expr. lvl, relative expression level).
Figure 2. Cholesterol biosynthesis in CSFV-infected PK-15 cells. (a) GO and KEGG enrichment for differentially expressed genes in CSFV-infected PK-15 cells. (b,c) The expression of gene involved in cholesterol biosynthesis was detected in CSFV-infected PK-15 cells; ** p < 0.01; *** p < 0.001; **** p < 0.0001. (M, mock; C, CSFV; Rel. expr. lvl, relative expression level).
Viruses 14 01450 g002
Viruses 14 01450 g003 550
Figure 3. PCSK9 expression and exogenous cholesterol uptake during CSFV infection. (a) The viral genome copies of CSFV in PK-15 cells at 48 hpi were detected by qPCR; n = 3; *** p < 0.001; **** p < 0.0001. (b) The detection of intracellular cholesterol levels in CSFV-infected PK-15 cells; n = 3; ** p < 0.01; **** p < 0.0001. (c,d) The protein-expression levels of LDLR and PCSK9; n = 3; * p < 0.05. (e,f) The detection of dil-LDL uptake in CSFV-infected PK-15 cells at 48 hpi; n = 3; *** p < 0.001. (g) The inhibition of PCSK9 expression did not affect CSFV replication; n = 3; **** p < 0.0001. (h) The disruption of LDLR did not affect CSFV replication; n = 3. (i,j) The uptake of dil-LDL was completely blocked by the deletion of LDLR; n = 3. (WT, wild-type; LO, ldlr-ko; M, mock; C, CSFV; Rel. prot. lvl, relative protein level; Ic. cholesterol, intracellular cholesterol level; MFI, mean fluorescent intensity).
Figure 3. PCSK9 expression and exogenous cholesterol uptake during CSFV infection. (a) The viral genome copies of CSFV in PK-15 cells at 48 hpi were detected by qPCR; n = 3; *** p < 0.001; **** p < 0.0001. (b) The detection of intracellular cholesterol levels in CSFV-infected PK-15 cells; n = 3; ** p < 0.01; **** p < 0.0001. (c,d) The protein-expression levels of LDLR and PCSK9; n = 3; * p < 0.05. (e,f) The detection of dil-LDL uptake in CSFV-infected PK-15 cells at 48 hpi; n = 3; *** p < 0.001. (g) The inhibition of PCSK9 expression did not affect CSFV replication; n = 3; **** p < 0.0001. (h) The disruption of LDLR did not affect CSFV replication; n = 3. (i,j) The uptake of dil-LDL was completely blocked by the deletion of LDLR; n = 3. (WT, wild-type; LO, ldlr-ko; M, mock; C, CSFV; Rel. prot. lvl, relative protein level; Ic. cholesterol, intracellular cholesterol level; MFI, mean fluorescent intensity).
Viruses 14 01450 g003
Viruses 14 01450 g004 550
Figure 4. Cholesterol biosynthesis regulates CSFV replication in PK-15 cells. (a,b) The disruption of cholesterol biosynthesis effectively reduced intracellular cholesterol contents and CSFV replication; n = 3; ** p < 0.01; *** p < 0.001; **** p < 0.0001. (c,d) The deficiency of cholesterol biosynthesis upregulated dil-LDL uptake and decreased intracellular cholesterol levels; n = 3; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. (e,f) (WT, wild-type; SO, sqle-ko; HO, hsd17b7-ko; Ic. cholesterol, intracellular cholesterol level; MFI, mean fluorescent intensity).
Figure 4. Cholesterol biosynthesis regulates CSFV replication in PK-15 cells. (a,b) The disruption of cholesterol biosynthesis effectively reduced intracellular cholesterol contents and CSFV replication; n = 3; ** p < 0.01; *** p < 0.001; **** p < 0.0001. (c,d) The deficiency of cholesterol biosynthesis upregulated dil-LDL uptake and decreased intracellular cholesterol levels; n = 3; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. (e,f) (WT, wild-type; SO, sqle-ko; HO, hsd17b7-ko; Ic. cholesterol, intracellular cholesterol level; MFI, mean fluorescent intensity).
Viruses 14 01450 g004
Table
Table 1. The primers used in cell clones’ genotyping-PCR. 
Table 1. The primers used in cell clones’ genotyping-PCR. 
PrimersSequences (5′ to 3′)Amplicon (bp)
LDLR-JDTGCATAGCCAGACTCTCTTGG904
TGTGATCTCCCATTGCAATCTA
SQLE-JDGGTGTCACCGAAGAAGCCTT819
GAACCTCCATATGCCGCTGG
HSD17B7-JDGGAAGGCTATTGCAAGTGCC933
TGGGTCTCACTGACGTCTCT
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Zou, X.; Lin, F.; Yang, Y.; Chen, J.; Zhang, H.; Li, L.; Ouyang, H.; Pang, D.; Tang, X. Cholesterol Biosynthesis Modulates CSFV Replication. Viruses 2022, 14, 1450. https://doi.org/10.3390/v14071450

AMA Style

Zou X, Lin F, Yang Y, Chen J, Zhang H, Li L, Ouyang H, Pang D, Tang X. Cholesterol Biosynthesis Modulates CSFV Replication. Viruses. 2022; 14(7):1450. https://doi.org/10.3390/v14071450

Chicago/Turabian Style

Zou, Xiaodong, Feng Lin, Yang Yang, Jiahuan Chen, Huanyu Zhang, Linquan Li, Hongsheng Ouyang, Daxin Pang, and Xiaochun Tang. 2022. "Cholesterol Biosynthesis Modulates CSFV Replication" Viruses 14, no. 7: 1450. https://doi.org/10.3390/v14071450

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop